Pfizer Price Increases Underscore Rebate Problem, HHS’ Hargan Says
Executive Summary
The Trump Administration remains convinced that rebates lead to high list prices and that reform of the system is needed, US HHS Deputy Secretary Eric Hargan emphasizes.